Sayuri Nitta

1.1k total citations
40 papers, 681 citations indexed

About

Sayuri Nitta is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Sayuri Nitta has authored 40 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 19 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Sayuri Nitta's work include Hepatitis C virus research (23 papers), Liver Disease Diagnosis and Treatment (14 papers) and Hepatitis B Virus Studies (13 papers). Sayuri Nitta is often cited by papers focused on Hepatitis C virus research (23 papers), Liver Disease Diagnosis and Treatment (14 papers) and Hepatitis B Virus Studies (13 papers). Sayuri Nitta collaborates with scholars based in Japan, United States and Pakistan. Sayuri Nitta's co-authors include Mamoru Watanabe, Seishin Azuma, Mina Nakagawa, Sei Kakinuma, Miyako Murakawa, Yasuhiro Asahina, Yasuhiro Itsui, Naoya Sakamoto, Masato Miyoshi and Yuki Nishimura‐Sakurai and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Sayuri Nitta

36 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sayuri Nitta Japan 15 489 408 170 107 104 40 681
Miyako Murakawa Japan 12 401 0.8× 330 0.8× 146 0.9× 101 0.9× 85 0.8× 31 583
Julia Dietz Germany 17 460 0.9× 401 1.0× 170 1.0× 171 1.6× 153 1.5× 50 776
Elisavet Serti United States 15 598 1.2× 516 1.3× 466 2.7× 100 0.9× 81 0.8× 24 1.1k
A Glässner Germany 13 344 0.7× 299 0.7× 414 2.4× 49 0.5× 58 0.6× 25 751
Noha G. Bader El Din Egypt 15 364 0.7× 350 0.9× 81 0.5× 167 1.6× 33 0.3× 47 614
Ewa Terczyńska‐Dyla Denmark 7 174 0.4× 204 0.5× 314 1.8× 70 0.7× 104 1.0× 12 556
Amy E.L. Stone United States 8 145 0.3× 133 0.3× 222 1.3× 114 1.1× 66 0.6× 15 412
Noboru Hirashima Japan 14 462 0.9× 459 1.1× 34 0.2× 191 1.8× 110 1.1× 51 817
Vincent Leroy France 17 828 1.7× 813 2.0× 307 1.8× 49 0.5× 82 0.8× 37 1.1k
Erwin Daniel Brenndörfer Sweden 13 250 0.5× 202 0.5× 151 0.9× 91 0.9× 41 0.4× 22 442

Countries citing papers authored by Sayuri Nitta

Since Specialization
Citations

This map shows the geographic impact of Sayuri Nitta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sayuri Nitta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sayuri Nitta more than expected).

Fields of papers citing papers by Sayuri Nitta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sayuri Nitta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sayuri Nitta. The network helps show where Sayuri Nitta may publish in the future.

Co-authorship network of co-authors of Sayuri Nitta

This figure shows the co-authorship network connecting the top 25 collaborators of Sayuri Nitta. A scholar is included among the top collaborators of Sayuri Nitta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sayuri Nitta. Sayuri Nitta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyoshi, Masato, Sei Kakinuma, Taro Shimizu, et al.. (2025). Crosstalk via ICAM-1 enhances supportive phenotype of stellate cells and drives hepatocyte proliferation in iPSC-derived hepatic organoids. Stem Cell Reports. 20(10). 102642–102642.
2.
Tsuchiya, Jun, Masato Miyoshi, Sei Kakinuma, et al.. (2024). Hepatitis B Virus-KMT2B Integration Drives Hepatic Oncogenic Processes in a Human Gene-edited Induced Pluripotent Stem Cells-derived Model. Cellular and Molecular Gastroenterology and Hepatology. 19(2). 101422–101422. 1 indexed citations
3.
Kaneko, Shun, Yasuhiro Asahina, Miyako Murakawa, et al.. (2024). Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades. PLoS ONE. 19(3). e0297882–e0297882.
4.
Yoshifuji, Kota, Yoshihiro Umezawa, Toshikage Nagao, et al.. (2024). Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma. Journal of Clinical and Experimental Hematopathology. 64(4). 313–317.
5.
Miyoshi, Masato, Sei Kakinuma, Ayako Sato, et al.. (2024). A20 in hepatic stellate cells suppresses chronic hepatitis by inhibiting DCLK1 – JNK pathway‐dependent chemokines. The FASEB Journal. 38(13). e23757–e23757. 2 indexed citations
6.
Nitta, Sayuri, et al.. (2022). Analysis of a Tuberculosis Outbreak in an Office. International Journal of Mycobacteriology. 11(3). 287–292. 6 indexed citations
7.
Nitta, Sayuri, Kazuaki Takahashi, Fukiko Kawai‐Kitahata, et al.. (2019). Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient. Hepatology Research. 50(4). 524–531. 1 indexed citations
8.
9.
Miyoshi, Masato, Sei Kakinuma, Akihide Kamiya, et al.. (2019). LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells. Scientific Reports. 9(1). 2072–2072. 19 indexed citations
10.
Nagata, Hiroko, Mina Nakagawa, Yasuhiro Asahina, et al.. (2017). Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C. Journal of Hepatology. 67(5). 933–939. 139 indexed citations
11.
12.
Nitta, Sayuri, Yasuhiro Asahina, Mami Matsuda, et al.. (2016). Effects of Resistance-Associated NS5A Mutations in Hepatitis C Virus on Viral Production and Susceptibility to Antiviral Reagents. Scientific Reports. 6(1). 34652–34652. 22 indexed citations
13.
Goto, Fumio, Sei Kakinuma, Masato Miyoshi, et al.. (2016). Bone morphogenetic protein‐4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells. Hepatology Research. 47(9). 941–952. 2 indexed citations
14.
Kakinuma, Sei, Akihide Kamiya, Naoya Sakamoto, et al.. (2013). Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in mice. Hepatology. 57(6). 2502–2513. 27 indexed citations
15.
Nitta, Sayuri, Naoya Sakamoto, Mina Nakagawa, et al.. (2012). Hepatitis C virus NS4B protein targets STING and abrogates RIG-I–mediated type I interferon-dependent innate immunity. Hepatology. 57(1). 46–58. 124 indexed citations
16.
Nakagawa, Mina, Naoya Sakamoto, Takako Watanabe, et al.. (2012). Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C. Hepatology International. 7(1). 153–161. 2 indexed citations
17.
Watanabe, Takako, Naoya Sakamoto, Mina Nakagawa, et al.. (2011). Inhibitory Effect of a Triterpenoid Compound, with or without Alpha Interferon, on Hepatitis C Virus Infection. Antimicrobial Agents and Chemotherapy. 55(6). 2537–2545. 16 indexed citations
18.
Suda, Goki, Naoya Sakamoto, Yasuhiro Itsui, et al.. (2010). IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones. Virology. 407(1). 80–90. 19 indexed citations
19.
Nitta, Sayuri, et al.. (2007). [Biliary tract carcinoma in elderly patients in whom gemcitabine chemotherapy induced complete remission - a report of two cases].. PubMed. 34(6). 941–3. 1 indexed citations
20.
Ito, Hiroki, et al.. (1994). [Eight cases of thymic carcinoma].. PubMed. 42(11). 2060–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miyako Murakawa Breakdown of academic impact, for papers by Julia Dietz Breakdown of academic impact, for papers by Elisavet Serti Breakdown of academic impact, for papers by A Glässner Breakdown of academic impact, for papers by Noha G. Bader El Din Breakdown of academic impact, for papers by Ewa Terczyńska‐Dyla Breakdown of academic impact, for papers by Amy E.L. Stone Breakdown of academic impact, for papers by Noboru Hirashima Breakdown of academic impact, for papers by Vincent Leroy Breakdown of academic impact, for papers by Erwin Daniel Brenndörfer
Rankless by CCL
2026